Vaxart outlines Phase IIb COVID-19 top line data in first half of 2027 backed by BARDA funding
World News Seeking Alpha Aug 8, 2026
Vaxart outlines Phase IIb COVID-19 top line data in first half of 2027 backed by BARDA funding
Vaxart outlines Phase IIb COVID-19 top line data in first half of 2027 backed by BARDA funding
World News Seeking Alpha Aug 8, 2026